Minze Health Revenue and Competitors
Estimated Revenue & Valuation
- Minze Health's estimated annual revenue is currently $9.2M per year.
- Minze Health's estimated revenue per employee is $307,200
- Minze Health's total funding is $10M.
Employee Data
- Minze Health has 30 Employees.
- Minze Health grew their employee count by 25% last year.
Minze Health's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CTO | Reveal Email/Phone |
3 | VP, Marketing & Sales | Reveal Email/Phone |
4 | Head Software | Reveal Email/Phone |
5 | VP Marketing & Sales | Reveal Email/Phone |
6 | BD Director | Reveal Email/Phone |
7 | R&D Manager | Reveal Email/Phone |
8 | CCO | Reveal Email/Phone |
Minze Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $10M | 33 | 27% | $10.9M | N/A |
#2 | $25.3M | 66 | 20% | N/A | N/A |
#3 | $9.2M | 30 | 25% | $10.5M | N/A |
#4 | $8.2M | 27 | 17% | N/A | N/A |
#5 | $25.6M | 67 | 24% | N/A | N/A |
What Is Minze Health?
Minze Health is an Antwerp based HealthTech start-up that builds creative Digital Health solutions with a focus on Urology and Pelvic Health.\n\nMinze Homeflow enables the urologist to collect multiple uroflowmetries & voiding diary data in the comfort of the patients’ daily life and the allows the clinician to access this data in an online portal. \nMinze Hospiflow is a patient-friendly, flexible alternative for the current stationary uroflowmeters in hospitals or private practices. No more need for a dedicated space for uroflowmetry, Hospiflow can be used on any toilet!\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
keywords:N/A$10M
Total Funding
30
Number of Employees
$9.2M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.5M | 30 | -14% | $15M |
#2 | $7.5M | 34 | 31% | N/A |
#3 | $6M | 36 | 50% | N/A |
#4 | $5.9M | 37 | -21% | N/A |
#5 | $4.1M | 39 | 8% | N/A |